Skip to main content

Table 1 Medications licensed and recommended for malaria chemoprophylaxis by various countries

From: The position of mefloquine as a 21st century malaria chemoprophylaxis

Medication approved and available for malaria chemoprophylaxis

United States

Canada

United Kingdom

France

Germany

Switzerland

Japan

Australia

Mefloquine

licensed

licensed

licensed

licensed

licensed

licensed

Licensed but not approved for use in children

Licensed but not approved for use in children <14 years old

Doxycycline*

for age ≥8 years

for age ≥8 years

for age ≥12 years

for age >8 years

Off Label

for age ≥8 years

-

for age >8 years

Atovaquone-proguanil

licensed

licensed

licensed

licensed

licensed

licensed

-

licensed

Primaquine

Only licensed for radical cure but is recommended as primary prophylaxis in CDC guideline

licensed

- not recommended for primary prophylaxis

-

-

not registered for primary prophylaxis

not registered for primary prophylaxis

-

Proguanil in combination with chloroquine

-

-

licensed

licensed °

licensed

licensed

-

licensed

  1. Adapted from Chen L, Wilson M, Schlagenhauf [49]
  2. + = licensed for malaria chemoprophylaxis and available in country.
  3. - = not licensed for malaria chemoprophylaxis or not available.
  4. * In some countries, doxycycline is licensed for specific indications but not malaria chemoprophylaxis. In Germany it is often used for this indication but not licensed for malaria prophylaxis "OFF LABEL" use.
  5. ° A fixed combination of chloroquine (100 mg base) and proguanil (200 mg) is available as Savarine® in France